Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Part of paid clinical trials in Fullerton, California.

Sponsor
HistoSonics, Inc.
Study ID
NCT06486454
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • HistoSonics Edison System — DEVICE
    Histotripsy with the HistoSonics Edison System for the full or partial destruction of liver tumors

Study Details

The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient characteristics and procedural characteristics may affect histotripsy success at 36 hours post-histotripsy procedure. Sub-studies to the BOOMBOX: Master Study will investigate specific populations and/or clinical questions with more stringent enrollment criteria, standardized testing criteria, and/or follow-up schedule. Any participant enrolled in the BOOMBOX: Master Study that also qualifies for a sub-study may enroll in the sub-study in parallel; sub-studies will be described in separate sub-study protocols. The BOOMBOX: Master Study will collect information about participants before, during, and after the histotripsy treatment procedure. All participants will be followed per standard clinical follow-up based on each site's clinical practice for up to 5 years after the initial histotripsy procedure or until completion of their follow-up in a sub-study, whichever is longer.

Key Dates

Start date
Oct 14, 2024
Status verified
Jun 2026
Primary completion
Nov 30, 2026
Completion
Nov 30, 2031

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: HistoSonics Edison System

Primary Outcome Measure

Histotripsy Technical Success [ Time Frame: ≤36 hours post-histotripsy treatment procedure ]

Central Contacts

Locations (30)

FacilityCityStateZIPSite coordinators
Providence St. JudeFullertonCalifornia92835
Veronica Aguilar
David Park, MD (PRINCIPAL_INVESTIGATOR)
Mission HospitalMission ViejoCalifornia92691
Kinnedy Houston
Kevin Burns, MD (PRINCIPAL_INVESTIGATOR)
HoagNewport BeachCalifornia92663
Trushar Patel, MD (PRINCIPAL_INVESTIGATOR)
Sutter Bay HospitalsSan FranciscoCalifornia94107
Maya Eshel
415-600-0865
Casey Ward, MD (PRINCIPAL_INVESTIGATOR)
Providence Saint John's Health CenterSanta MonicaCalifornia90404
Joey Dumadag
Paul Shin, MD (PRINCIPAL_INVESTIGATOR)
AdventHealth Altamonte SpringsAltamonte SpringsFlorida32701-
AdventHealth CelebrationCelebrationFlorida34747
Andrea Chiriboga
Andrew Guzowski, MD (PRINCIPAL_INVESTIGATOR)
Lee Health Cancer InstituteFort MyersFlorida33905
Lee Health Research Department
Mark Bloomston, MD (PRINCIPAL_INVESTIGATOR)
Baptist Health Miami Cardiac & Vascular InstituteMiamiFlorida33176-
Northeast Georgia Medical CenterGainesvilleGeorgia30501
Terence Jackson, MD (PRINCIPAL_INVESTIGATOR)
RUSH University Medical CenterChicagoIllinois60612
Karl Villanueva
Jordan Tasse, MD (PRINCIPAL_INVESTIGATOR)
University of ChicagoChicagoIllinois60637
Tiana Jackson
Abdul Khan, MD (PRINCIPAL_INVESTIGATOR)
Willis Knighton HealthShreveportLouisiana71103
Briana Barrow
Gazi Zibari, MD (PRINCIPAL_INVESTIGATOR)
Mass General BrighamBostonMassachusetts02115
Maggie Connolly
Jiping Wang, MD, PhD (PRINCIPAL_INVESTIGATOR)
Henry Ford HealthDetroitMichigan48202
Niya Boby
313-916-4596
Atsushi Yoshida, MD (PRINCIPAL_INVESTIGATOR)
University of Michigan Health - WestWyomingMichigan49519
Jensen Jantz
Michael Koets, MD (PRINCIPAL_INVESTIGATOR)
Renown Regional Medical CenterRenoNevada89502
Katie Buckley
Nick Manguso, MD (PRINCIPAL_INVESTIGATOR)
Columbia University Irving Medical CenterNew YorkNew York10032
Stephen Reis, MD (PRINCIPAL_INVESTIGATOR)
NYU Langone HealthNew YorkNew York10016
Stanley Cobos
Brock Hewitt, MD (PRINCIPAL_INVESTIGATOR)
Weill Cornell MedicineNew YorkNew York10065
Nishtha Singh
Juan Rocca, MD (PRINCIPAL_INVESTIGATOR)
University of Rochester Medical CenterRochesterNew York14642
Cristina Jimenez-Soto
Koji Tomiyama, MD (PRINCIPAL_INVESTIGATOR)
Novant HealthWinston-SalemNorth Carolina27103
Alison Rankin
David Sindram, MD (PRINCIPAL_INVESTIGATOR)
Miami Valley Hospital SouthCentervilleOhio45459
Katie Pugh
937-438-7815
James Ouellette, MD (PRINCIPAL_INVESTIGATOR)
Cleveland Clinic FoundationClevelandOhio44195
Erlind Allkushi
Jaekeun Kim, MD (PRINCIPAL_INVESTIGATOR)
The Ohio State UniversityColumbusOhio43210
Gage Spears
614-293-8315
Mina Makary, MD (PRINCIPAL_INVESTIGATOR)
Lehigh Valley HospitalAllentownPennsylvania18103
Jessie Panick
Errin Hoffman, MD (PRINCIPAL_INVESTIGATOR)
St. David's Medical CenterAustinTexas78705
Krishna Saini
Shaun McKenzie, MD (PRINCIPAL_INVESTIGATOR)
Henrico Doctors' HospitalRichmondVirginia23229
Megan Edwards
423.779.2720
Laurie Cuttino, MD (PRINCIPAL_INVESTIGATOR)
Swedish Medical CenterSeattleWashington98122
Evan Ong, MD (PRINCIPAL_INVESTIGATOR)
University of WisconsinMadisonWisconsin53792
Caitlin Normoyle
John Swietlik, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Fullerton, CA

By condition

Related Studies